Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.826 EUR | +2.70% | +16.16% | -59.78% |
10/07 | Markets Powered by Alternating Current | |
10/07 | Crossject Gets EUR7 Million Public Funding for New Epinephrine Product | MT |
Evolution of the average Target Price on Crossject
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALCJ Stock
- 74C Stock
- Consensus Crossject